Praveen Kumar Marimuthu

Praveen Kumar Marimuthu highlights EMBRACE II as a new standard of care for locally advanced cervical cancer

Praveen Kumar Marimuthu, DM Resident in Medical Oncology at the Christian Medical College and Hospital, shared a post on X:

“EMBRACE II sets new SOC for ChemoRT in LA cervical cancer!

  • 3-yr outcomes:
  • Local control 93%
  • Nodal control 91%
  • Disease-specific survival 89%
  • PFS 78%
  • OS 87%
  • G3–G5 toxicity: 9% (G4 <1%, G5 <0.2%)”

Praveen Kumar Marimuthu

Learn more about cervical cancer on OncoDaily.

cancer cervical cancer Christian Medical College and Hospital EMBRACE II OncoDaily Oncology Praveen Kumar Marimuthu